throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________
`
`DAIICHI SANKYO, INC. AND
`ASTRAZENECA PHARMACEUTICALS, LP
`Petitioners,
`
`v.
`
`SEAGEN INC.
`Patent Owner.
`
`Case No. PGR2021-00042
`Patent 10,808,039
`
`_______________
`
`____________________________________________________________
`
`PATENT OWNER’S SURREPLY
`
`

`

`PGR2021-00042
`
`
`
`Petitioners’ Reply fails to cure the weakness in their Petition, as the Fintiv
`
`factors as a whole favor discretionary denial.
`
`Factor 1 (Neutral). Petitioners’ representation that “[u]pon institution,
`
`Daiichi Sankyo Co., Ltd. will seek a stay” fails to render a stay more likely, as the
`
`Board has cautioned against speculation as to a district court’s ruling on Factor 1.
`
`Western Digital Corp. v. Kuster, No. IPR2020-01391, Paper 10 at 8-9 (P.T.A.B.
`
`Feb. 16, 2021) (factor 1 neutral despite expressed intent to move for a stay upon
`
`institution). Moreover, the available data do not support Petitioners’ claim that
`
`Judge Gilstrap granted a stay in 88% of post-institution cases. In reality, 22 of 30
`
`(73%) post-institution stay requests were granted, and of those, 16 were issued on
`
`stipulated, unopposed, or patent owner-initiated motions. (Ex. 2037.) Only six
`
`(27.3%) post-institution stay grants involved opposed motions by the challenger.
`
`(Ex. 2038.) If the Board credits Petitioner’s promise of a post-institution motion to
`
`stay, similar weight should be afforded Seagen’s intent to oppose any such motion.
`
`Factor 2 (Favors Denial). Petitioners’ Reply fails to offer any response to
`
`the Board’s decision that this factor “strongly favor[s] denying institution” where
`
`the trial date predates the final written decision by months. Apple Inc. v. Pinn,
`
`Inc., No. PGR2020-00066, Paper 16 at 11-12 (P.T.A.B. Dec. 8, 2020). Petitioners’
`
`citation to Western Digital does little to help their argument, as in that case the
`
`Board found Factor 2 to be neutral in large part because the same judge had
`
`sf-4494316
`
`1
`
`

`

`PGR2021-00042
`
`postponed other trials due to COVID-19 shortly before the institution decision. As
`
`explained in the Preliminary Response, Judge Gilstrap has resumed jury trials in
`
`other cases, and COVID-related uncertainties are continuing to diminish.
`
`Factor 3 (Favors Denial). Petitioners are wrong that Seagen only “focuses
`
`on investment after institution.” (Reply at 2.) Seagen’s Preliminary Response
`
`detailed the parties’ entire investment, both actual and projected, before and after
`
`institution. In the month since, the parties have begun claim construction
`
`proceedings, taken additional depositions, served additional discovery responses,
`
`and produced additional documents. Before the Board’s institution decision,
`
`Seagen will have filed its opening claim construction brief, with the responsive
`
`claim construction brief due merely days after the Board’s institution decision.
`
`Petitioners’ argument that “[o]nly investment completed ‘at the time of the
`
`institution decision’ is relevant” misstates the law. (Reply at 2 (citing Dolby Labs.,
`
`Inc. v. Intertrust Techs. Corp., No. IPR2020-01123, Paper 10 at 19 (P.T.A.B. Jan.
`
`6, 2021)) (emphasis in original).) In Dolby, significant post-institution investment
`
`merely led the Board to find that Factor 3 does “not weigh for or against”
`
`discretionary denial, not deem the post-institution investment irrelevant. Dolby
`
`Labs., No. IPR2020-01123, Paper 10 at 21. Thus, even accepting Petitioners
`
`inaccurate characterization of the record, Factor 3 would at best come out as
`
`neutral and not, as Petitioners claim, in favor of institution.
`
`sf-4494316
`
`2
`
`

`

`PGR2021-00042
`
`
`Factor 4 (Favors Denial). Petitioners again rely on the speculative
`
`assertion that the “litigation likely will be stayed.” (Reply at 3.) Petitioners did
`
`not—and indeed cannot—refute the fact that their Petition relies on identical
`
`grounds for unpatentability as those at issue in the Texas Action.
`
`Factor 5 (Favors Denial). Petitioners persist in pressing the cosmetic
`
`technicality that “[n]either petitioner is a defendant in Texas” (Reply at 3) and fail
`
`to acknowledge their own admission that the Texas defendant is a real party-in-
`
`interest to this Petition. (Pet. at 82.) Petitioners’ Reply likewise offers no rebuttal
`
`to the fact that Petitioner AstraZeneca has already participated in discovery in the
`
`Texas Action, and may still intervene in that action to fully prosecute its claims
`
`relating to the same patent at issue in this proceeding.
`
`Factor 6 (Favors Denial). Petitioners contend that “PO opted not to
`
`respond at all to multiple arguments.” (Reply at 3.) Petitioners’ anticipation
`
`argument, however, is fully rebutted by Seagen’s response to the priority
`
`argument, because alleged lack of priority is the only basis in the Petition for any
`
`cited reference to qualify as prior art. Seagen also provided multiple arguments in
`
`response to Petitioner’s Ground 2 on the basis of lack of enablement. Petitioners’
`
`conclusory assertion that their “unpatentability grounds . . . are particularly strong”
`
`(id.) does not change the fact that their petition suffers from numerous fundamental
`
`flaws, as outlined in the preliminary response.
`
`sf-4494316
`
`3
`
`

`

`PGR2021-00042
`
`Dated: May 26, 2021
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`By: /Matthew I. Kreeger/
`Matthew I. Kreeger, Reg. No. 56,398
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105
`Tel: (415) 268-6467
`Fax: (415) 268-7522
`
`
`Attorney for Patent Owner
`
`sf-4494316
`
`4
`
`

`

`PGR2021-00042
`
`
`Certificate of Service (37 C.F.R. § 42.6(e)(4))
`
`I hereby certify that the attached PATENT OWNER’S SURREPLY was
`
`served as of the below date via email on the Petitioner at the following
`
`correspondence address:
`
`Preston K. Ratliff II
`Naveen Modi
`Michael A. Stramiello, Ph.D.
`Paul Hastings LLP
`200 Park Avenue, New York, NY, 10166
`Daiichi_Sankyo-Seagen-PGR-PH@paulhastings.com
`
`David I. Berl
`Thomas S. Fletcher
`Williams & Connolly LLP
`725 12th St. NW
`Washington, DC, 20005
`Enhertu@wc.com
`
`
`
`Dated: May 26, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`By: /Matthew I. Kreeger/
`Matthew I. Kreeger, Reg. No. 56,398
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105
`Tel: (415) 268-6467
`Fax: (415) 268-7522
`
`sf-4494316
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket